Nepal allows Chinese mRNA vaccine candidate to conduct Phase III clinical trials macaubusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from macaubusiness.com Daily Mail and Mail on Sunday newspapers.
The world s first aerosolized inhaled adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV), jointed developed by CanSino Biologics (CanSinoBIO) and researchers from the Institute of Military Medicine under the Academy of Military Sciences led by Chen Wei, was proven safe in Phase-I clinical trials, the Global Times learned from CanSinoBIO on Wednesday.
The trial showed that two doses of aerosol Ad5-nCoV was well tolerated, without causing any vaccine-related serious adverse events, CanSinoBIO said.
The trial found that an aerosolized booster vaccination taken 28 days after the first intramuscular injection induced strong IgG and neutralizing antibody responses, said the report of the trial, which was published on The Lancet Infectious Diseases on Monday.
China Virus, Indeed | Frontpagemag frontpagemag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from frontpagemag.com Daily Mail and Mail on Sunday newspapers.
Written by rjs, MarketWatch 666The news posted last week for the coronavirus 2019-nCoV (aka SARS-CoV-2), which produces COVID-19 disease, has been surveyed and some important articles are summarized here. The articles are more or less organized with general virus news and anecdotes first, then stories from around the US, followed by an increased number of items from other countries around the globe. Economic news related to COVID-19 is found here.